Research programme: coronavirus vaccine - Baxter Healthcare
Latest Information Update: 08 Mar 2011
At a glance
- Originator Baxter Healthcare Corporation
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Coronavirus infections
Most Recent Events
- 12 Sep 2006 This vaccine is still in preclinical development